Replies to post #565075 on NorthWest Biotherapeutics Inc (NWBO)

[jondoeuk]

The Journal Article Peer reviewed by over 70 Doctors and research analysis is enough evidence to convince anybody of average intelligence that DCVAX extends the life of many over the SOC.

Only if you ignore the history of the trial, data, and haven't read the different comments, including Dr. Williams et al. In addition, various other expert opinions, such that of Dr. Stupp.

Optune's TTF device has never extended life

An efficacy interim analysis presented in 2015 demonstrated improved PFS, unlike NW's vaccine. The final trial was published in 2017, which reported an improvement in OS. Again, unlike the vaccine.

and more importantly it reduces the quality of life during the few precious remaining months of life

Grade 3 skin irritation was two percent.

I as many others on this board have witnessed this first hand.

The plural of anecdote is anecdotes, not data.